These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28986592)

  • 41. Diffusion and Protein Corona Formation of Lipid-Based Nanoparticles in the Vitreous Humor: Profiling and Pharmacokinetic Considerations.
    Tavakoli S; Kari OK; Turunen T; Lajunen T; Schmitt M; Lehtinen J; Tasaka F; Parkkila P; Ndika J; Viitala T; Alenius H; Urtti A; Subrizi A
    Mol Pharm; 2021 Feb; 18(2):699-713. PubMed ID: 32584047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.
    Kim H; Robinson SB; Csaky KG
    Pharm Res; 2009 Feb; 26(2):329-37. PubMed ID: 18958405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
    Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
    Daull P; Paterson CA; Kuppermann BD; Garrigue JS
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitreous: a barrier to nonviral ocular gene therapy.
    Peeters L; Sanders NN; Braeckmans K; Boussery K; Van de Voorde J; De Smedt SC; Demeester J
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3553-61. PubMed ID: 16186333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyaluronic Acid Graft Copolymers with Cleavable Arms as Potential Intravitreal Drug Delivery Vehicles.
    Borke T; Najberg M; Ilina P; Bhattacharya M; Urtti A; Tenhu H; Hietala S
    Macromol Biosci; 2018 Jan; 18(1):. PubMed ID: 28834620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arginine-Modified Nanostructured Lipid Carriers with Charge-Reversal and pH-Sensitive Membranolytic Properties for Anticancer Drug Delivery.
    Sun M; Li J; Zhang C; Xie Y; Qiao H; Su Z; Oupický D; Ping Q
    Adv Healthc Mater; 2017 Apr; 6(8):. PubMed ID: 28187243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization.
    Robinson MR; Baffi J; Yuan P; Sung C; Byrnes G; Cox TA; Csaky KG
    Exp Eye Res; 2002 Feb; 74(2):309-17. PubMed ID: 11950241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chitosan-decorated selenium nanoparticles as protein carriers to improve the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2 diabetes mellitus.
    Rao L; Ma Y; Zhuang M; Luo T; Wang Y; Hong A
    Int J Nanomedicine; 2014; 9():4819-28. PubMed ID: 25378923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clearance of intravitreal voriconazole.
    Shen YC; Wang MY; Wang CY; Tsai TC; Tsai HY; Lee YF; Wei LC
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2238-41. PubMed ID: 17460285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
    Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrasound-responsive nanobubbles for enhanced intravitreal drug migration: An ex vivo evaluation.
    Thakur SS; Chen YS; Houston ZH; Fletcher N; Barnett NL; Thurecht KJ; Rupenthal ID; Parekh HS
    Eur J Pharm Biopharm; 2019 Mar; 136():102-107. PubMed ID: 30660691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simulation of drug distribution in the vitreous body after local drug application into intact vitreous body and in progress of posterior vitreous detachment.
    Loch C; Bogdahn M; Stein S; Nagel S; Guthoff R; Weitschies W; Seidlitz A
    J Pharm Sci; 2014 Feb; 103(2):517-26. PubMed ID: 24311438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liposomes for intravitreal drug delivery: a state of the art.
    Bochot A; Fattal E
    J Control Release; 2012 Jul; 161(2):628-34. PubMed ID: 22289436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of intravitreal ranibizumab (Lucentis).
    Bakri SJ; Snyder MR; Reid JM; Pulido JS; Ezzat MK; Singh RJ
    Ophthalmology; 2007 Dec; 114(12):2179-82. PubMed ID: 18054637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
    Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle.
    Cheng L; Anglin E; Cunin F; Kim D; Sailor MJ; Falkenstein I; Tammewar A; Freeman WR
    Br J Ophthalmol; 2008 May; 92(5):705-11. PubMed ID: 18441177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.